BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22736254)

  • 21. Differential effects on CLL cell survival exerted by different microenvironmental elements.
    Ghia P; Circosta P; Scielzo C; Vallario A; Camporeale A; Granziero L; Caligaris-Cappio F
    Curr Top Microbiol Immunol; 2005; 294():135-45. PubMed ID: 16323430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
    Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
    PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.
    Secchiero P; Barbarotto E; Gonelli A; Tiribelli M; Zerbinati C; Celeghini C; Agostinelli C; Pileri SA; Zauli G
    Am J Pathol; 2005 Dec; 167(6):1599-607. PubMed ID: 16314473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
    Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
    Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
    Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
    Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
    Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
    Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
    Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
    Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
    Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
    Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
    Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
    Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
    Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
    Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.
    Bagnara D; Kaufman MS; Calissano C; Marsilio S; Patten PE; Simone R; Chum P; Yan XJ; Allen SL; Kolitz JE; Baskar S; Rader C; Mellstedt H; Rabbani H; Lee A; Gregersen PK; Rai KR; Chiorazzi N
    Blood; 2011 May; 117(20):5463-72. PubMed ID: 21385850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
    Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
    Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
    Lee YK; Bone ND; Strege AK; Shanafelt TD; Jelinek DF; Kay NE
    Blood; 2004 Aug; 104(3):788-94. PubMed ID: 14996703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.
    Zheng Z; Venkatapathy S; Rao G; Harrington CA
    Leukemia; 2002 Dec; 16(12):2429-37. PubMed ID: 12454749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.